Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Protein and energy interactions during hyperinsulinemic euglycemic clamp in critically ill septic children
NL-OMON33362Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of human insulin in sepsis, Systemic Inflammatory Response Syndrome (SIRS), septic shock and 1 more (2 arms), sponsored by Erasmus MC. Primary endpoint: Whole body protein balance. Started Nov 2009; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
sepsisSystemic Inflammatory Response Syndrome (SIRS)septic shockinsulin resistance (IR)
Beyond the preview
Go deeper on NL-OMON33362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33362.